================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 29, 2003
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
Delaware 1-1136 22-079-0350
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
345 Park Avenue
New York, NY, 10154
(Address of Principal Executive Office)
Registrant's telephone number, including area code: (212) 546-4000
================================================================================
Item 7. Financial Statements and Exhibit
(c) Exhibit
Exhibit 99 Press Release of Bristol-Myers Squibb Company dated
April 29, 2003, reporting Bristol-Myers Squibb's
financial results for the first quarter of 2003.
Item 9. Regulation FD disclosure
Incorporated by reference is a press release issued by the Registrant on
April 29, 2003 regarding earnings for the first quarter of 2003, attached as
Exhibit 99. This information is being furnished pursuant to Item 12 - Results of
Operations and Financial Condition, on Form 8-K and is being presented under
Item 9 of Form 8-K in accordance with interim guidance issued by the Securities
and Exchange Commission in Release Nos. 33-8216 and 34-47583. This information
is not deemed to be "filed" for the purposes of Section 18 of the Securities
Exchange Act of 1934 and is not incorporated by reference into any Securities
Act registration statements.
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant
has caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
BRISTOL-MYERS SQUIBB COMPANY
By: (s) Sandra Leung
---------------------------------------
Sandra Leung
Title: Vice President and Secretary
Dated: April 29, 2003
EXHIBIT INDEX
Exhibit No. Description
99 Press Release of Bristol-Myers Squibb Company dated April 29,
2003, reporting Bristol-Myers Squibb's financial results for the
first quarter of 2003.